Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
ESMO Open
|
June 26, 2022
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
F Janku, S Bauer, K Shoumariyeh, et al.
Archives of Virology
|
January 1, 1990
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis
L Lozzi, M Rustici, M Corti, et al.
British Journal of Cancer
|
January 8, 2004
Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)
F Cappuzzo, S Bartolini, G L Ceresoli, et al.
Clinical and Experimental Rheumatology
|
May 18, 2004
Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis
B Frediani, F Baldi, P Falsetti, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
April 17, 2007
Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients
Zh Mihaylova, V Ludovini, V Gregorg, et al.
Clinical Pharmacology and Therapeutics
|
August 24, 2007
Germline polymorphisms in EGFR and survival in patients with lung cancer receiving gefitinib
V Gregorc, M Hidalgo, A Spreafico, et al.
British Journal of Cancer
|
January 28, 2015
A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies
A Spreafico, J-P Delord, L De Mattos-Arruda, et al.
Clinical and Experimental Rheumatology
|
September 19, 2008
Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes
E Selvi, S Lorenzini, E Garcia-Gonzalez, et al.
Oral Oncology
|
May 29, 2020
Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck
D Day, A Prawira, A Spreafico, et al.
Gynecologic Oncology
|
January 8, 2017
Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC)
A Spreafico, A M Oza, B A Clarke, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
ESMO Open
|
June 26, 2022
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
F Janku, S Bauer, K Shoumariyeh, et al.
Archives of Virology
|
January 1, 1990
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis
L Lozzi, M Rustici, M Corti, et al.
British Journal of Cancer
|
January 8, 2004
Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)
F Cappuzzo, S Bartolini, G L Ceresoli, et al.
Clinical and Experimental Rheumatology
|
May 18, 2004
Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis
B Frediani, F Baldi, P Falsetti, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
April 17, 2007
Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients
Zh Mihaylova, V Ludovini, V Gregorg, et al.
Clinical Pharmacology and Therapeutics
|
August 24, 2007
Germline polymorphisms in EGFR and survival in patients with lung cancer receiving gefitinib
V Gregorc, M Hidalgo, A Spreafico, et al.
British Journal of Cancer
|
January 28, 2015
A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies
A Spreafico, J-P Delord, L De Mattos-Arruda, et al.
Clinical and Experimental Rheumatology
|
September 19, 2008
Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes
E Selvi, S Lorenzini, E Garcia-Gonzalez, et al.
Oral Oncology
|
May 29, 2020
Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck
D Day, A Prawira, A Spreafico, et al.
Gynecologic Oncology
|
January 8, 2017
Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC)
A Spreafico, A M Oza, B A Clarke, et al.
Page
of 4